In This Section      
Print This Page

Current News Releases - 2018

Current News Releases

2018
Released: February 20, 2018


In an analysis of clinical data collected on more than 9,000 people, Johns Hopkins researchers have shown that the number of years spent overweight or obese appear to “add up” to a distinct risk factor that makes those with a longer history of heaviness more likely to test positive for a chemical marker of so-called “silent” heart damage than those with a shorter history
Released: February 20, 2018

Researchers call for “standard pricing” legislation to reduce financial burdens of vulnerable patients


An analysis of recent Medicare billing records for more than 3,000 hospitals across the United States shows that charges for outpatient oncology services such as chemo infusion or radiation treatment vary widely and exceed what Medicare will pay by twofold to sixfold.

Released: February 13, 2018


As the Winter Olympics begin, the world will be marveling at feats performed by athletes at the top of their game. But how do judges distinguish, in just a split second, a gold medal-winning performance from a silver?
Released: February 12, 2018


In an editorial that draws on results of previously published studies and experiences in their medical intensive care unit (ICU), a team of Johns Hopkins Medicine professionals say that bringing specially trained dogs into ICUs can safely and substantially ease patients’ physical and emotional suffering.

Released: February 12, 2018


Below are brief summaries of story ideas for February’s Valentine’s Day and American Heart Month
Released: February 12, 2018


Johns Hopkins researchers report successful use of heart imaging to predict the benefit or futility of catheter ablation, an increasingly popular way to treat atrial fibrillation, a common heart rhythm disorder.

Released: February 9, 2018


The Johns Hopkins University School of Medicine’s Brancati Center will provide free community health screenings this Saturday, Feb. 10, at A Family Affair, an event hosted by Living Classrooms. RSVP encouraged: email tiztraining@livingclassrooms.org or call (443) 835-1463 x667 to register.

Released: February 8, 2018


Johns Hopkins researchers report they have developed two new endoscopic probes that significantly sharpen the technology’s imaging resolution and permit direct observation of fine tissue structures and cell activity in small organs in sheep, rats and mice
Released: February 7, 2018

Findings suggest opportunity to increase organ supply, save lives


In a new Johns Hopkins study of patient and graft survival trends for pediatric liver transplant recipients between 2002 and 2015, researchers found that outcomes for alternatives to whole liver transplantation (WLT), such as splitting a liver for two recipients or using a part of a liver from a living donor, have improved significantly.
Released: February 6, 2018


A new Johns Hopkins study of mice with the rodent equivalent of metabolic syndrome has added to evidence that the intestinal microbiome — a “garden” of bacterial, viral and fungal genes — plays a substantial role in the development of obesity and insulin resistance in mammals, including humans.
Released: February 5, 2018


After years of investigation, researchers at Johns Hopkins, the University of California, Davis, and the National Institute of Allergy and Infectious Diseases have discovered how the immune system might protect a person from recurrent bacterial skin infections caused by Staphylococcus aureus (staph).
Released: February 5, 2018


Enrolling in Medicaid may have health benefits not only for low-income parents but also for their children, according to a Johns Hopkins analysis of over 50,000 parent-child pairs.

Released: February 1, 2018

$50 million gift to transform research and care of stroke globally


A new institute for stroke research and clinical care was announced today by the United Arab Emirates (UAE) Embassy in Washington, D.C., and Johns Hopkins. The Sheikh Khalifa Stroke Institute, funded by a $50 million gift from the United Arab Emirates, will focus Johns Hopkins’ efforts to leverage advances in engineering, artificial intelligence and precision medicine to better diagnose, treat and restore function to stroke patients. The gift is believed to be the largest ever for a stroke-specific initiative.  
Released: February 1, 2018

Two species may work together to drive tumor formation in hereditary colon cancer syndrome and sporadic colon cancer


Patients with an inherited form of colon cancer harbor two bacterial species that collaborate to encourage development of the disease, and the same species have been found in people who develop a sporadic form of colon cancer, a study led by a Johns Hopkins Bloomberg~Kimmel Institute for Cancer Immunotherapy research team finds.
Released: February 1, 2018


In a study of 61 people treated for the bacteria that causes Lyme disease, Johns Hopkins researchers conclude that fatigue, pain, insomnia and depression do indeed persist over long periods of time for some people, despite largely normal physical exams and clinical laboratory testing.
Released: January 30, 2018


Today, the Global Council on Brain Health (GCBH), an independent collaborative of international scientists, health professionals, scholars and policy experts convened by AARP, published Brain Food
Released: January 24, 2018

New research discovers two proteins pivotal to maintaining cancer stem cells, which cause chemotherapy resistance


Two different proteins work separately as well as synergistically to feed a small pool of stem cells that help bladder cancer resist chemotherapy, research led by a Johns Hopkins Kimmel Cancer Center scientist suggests. The finding, published online in Cancer Research, could lead to new targets to fight this deadly disease and potentially other cancers as well.

Released: January 24, 2018


Through the haze of a sonogram screen, an expectant mother catches a glimpse of the growing baby within her. The outline of a nose, chin and head, instantly recognizable as a tiny human, brings to life what parents, until then, could only imagine. Biologists, too, aim to bring their scientific discoveries to life by creating three-dimensional models—at the atomic level—of the inner workings of cells.
Released: January 23, 2018


Despite efforts over the past two decades to increase the number of black and Hispanic patients receiving kidney transplants from related or unrelated living donors, these racial/ethnic minority patients are still much less likely to undergo such transplants than white patients, Johns Hopkins researchers report. In fact, the investigators say, the disparities have worsened in the last 20 years.

Released: January 22, 2018

Johns Hopkins researcher and his team describe an approach they say could transform the field of diagnostic quality and safety


In an effort to reduce patient misdiagnoses and associated poor patient outcomes from lack of prompt treatment, a Johns Hopkins Armstrong Institute for Patient Safety and Quality researcher is helping to lead the way in providing hospitals a new approach to quantify and monitor diagnostic errors in their quality improvement efforts. The approach, called Symptom-Disease Pair Analysis of Diagnostic Error, or SPADE, is featured in a paper published today in BMJ Quality & Safety.

Released: January 22, 2018


In an assessment of their “depression literacy” program, which has already been taught to tens of thousands, Johns Hopkins researchers say the Adolescent Depression Awareness Program (ADAP) achieved its intended effect of encouraging many teenagers to speak up and seek adult help for themselves or a peer. 

Released: January 18, 2018

Provides unique new framework for early detection of the most common cancers


Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

Released: January 18, 2018


Data collected during a long-term health study provides additional evidence for a link between increased risk of cancer in individuals with advanced gum disease, according to a new collaborative study led by researchers at the Johns Hopkins Bloomberg School of Public Health, Johns Hopkins Kimmel Cancer Center and Tufts University School of Medicine and Cancer Center.
Released: January 16, 2018


Experiments with a small group of overweight men and women have added to evidence that “hunger hormone” levels rise and “satiety (or fullness) hormone” levels decrease in the evening. The findings also suggest that stress may increase hunger hormone levels more in the evening, and the impact of hormones on appetite may be greater for people prone to binge eating.

Released: January 16, 2018


A new study that seeks to ascertain HIV mortality rates in Zambia could provide a model for improved national and regional surveillance approaches and, ultimately, more effective HIV treatment strategies.

Released: January 11, 2018


Johns Hopkins hopes to become the first hospital in the U.S. to perform HIV-positive to HIV-positive organ transplants from living donors.

Released: January 10, 2018


What is precision medicine? It’s the practice of tailoring specific treatments to individual patients. Sometimes this involves making connections between a patient’s distinct genetic code and treatments that target that code, but it also takes into account a patient’s environment and lifestyle. Rather than the typical approach of prescribing treatments based on averages among patient populations, precision medicine has been the rallying cry of health care experts longing for better ways to match patients with customized care.
Released: January 8, 2018

Leading Causes of Death Are Prematurity and Injuries


In a new study of childhood mortality rates between 1961 and 2010 in the United States and 19 economically similar countries, researchers report that while there’s been overall improvement among all the countries, the U.S. has been slowest to improve.

Released: January 8, 2018


Johns Hopkins scientists have used a form of artificial intelligence to create a map that compares types of cellular receptors, the chemical “antennas” on the surface of immune system T-cells. Their experiments with lab-grown mouse and human T-cells suggest that people with cancer who have a greater variety of such receptors may respond better to immunotherapy drugs and vaccines.

Released: January 4, 2018

Project funded by collaboration between The Johns Hopkins University and Deerfield Management aims to develop first-in-class small molecule drug


Bluefield Innovations, a collaboration between The Johns Hopkins University and Deerfield Management to catalyze early stage therapeutic development, announced today the acceptance and funding of its first project. The target, the enzyme RNA polymerase I (Pol I), is implicated in many forms of cancer.
Released: January 3, 2018

Epilepsy drug reverses anti-social behaviors in mice with genes that produce variant proteins


Researchers at Johns Hopkins Medicine report they have identified rare genetic variations in a protein called Thorase, which is responsible for breaking down receptors at the connections between neurons in the brain.
Released: January 3, 2018


Johns Hopkins Medicine International (JHI) and the National Healthcare Group (NHG) today announced that their 20-year partnership has progressed to a new phase, with their Johns Hopkins Singapore International Medical Centre (JHSIMC) joint venture evolving into the new NHG-Johns Hopkins Singapore Institute.
Released: January 2, 2018

Studies suggest potential for reversing progressive vision loss


Johns Hopkins researchers have discovered a cell signaling pathway in mice that triggers vision loss in patients with diabetic retinopathy and retinal vein occlusion – diseases characterized by the closure of blood vessels in the retina, leading to blindness. In experiments that suppressed vascular endothelial growth factor (VEGF) in the eye, researchers were able to re-establish normal blood flow in the retina, offering a potential means of stalling or even reversing diabetes-related blindness.

Released: January 2, 2018

Assessment shown to be more accurate than a standard test for nonfasters


In a direct comparison study, Johns Hopkins researchers have added to evidence that a newer method of calculating so-called “bad cholesterol” levels in the blood is more accurate than the older method in people who did not fast before blood was drawn.